Expertise

Scientist practitioners

Led by world-renowned experts, we can undertake health preference, health outcomes and health economic studies completely in-house, with bespoke survey development securely running on our own servers. Our team has developed methods and contributed to the development of guidance in the field of health preference research. We are known because of our knowledge of quantitative expertise and our solid track records of publications in scientific journals.

Expertise

Some of our publications

Testing the "Nonstopping" Time Trade-Off: Is It Better Than the Composite Time Trade-Off?

Value in Health. 2020 Nov;23(11):1489-1496
doi: https://doi.org/10.1016/j.jval.2020.07.006

Testing the "Nonstopping" Time Trade-Off: Is It Better Than the Composite Time Trade-Off?

Luo N, Augestad L, Rand K.

Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L

Journal of Patient-Reported Outcomes. 2020 Nov 9;4(1):92
doi: https://doi.org/10.1186/s41687-020-00247-0

Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L

Rand K, Arnevik EA, Walderhaug E.

Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?

Value in Health. 2020 Apr;23(4):487-494
doi: https://doi.org/10.1016/j.jval.2019.10.003

Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?

Augestad LA, Rand K, Luo N, Barra M.

Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010-2015

BMC Health Services Research. 2019 Oct 16;19(1):705
doi: https://doi.org/10.1186/s12913-019-4538-7

Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010-2015

Rand K, Dahl FA, Viana J, Rønning OM, Faiz KW, Barra M.

EQ-5D-5L Valuation for the Malaysian Population

PharmacoEconomics. 2019 May;37(5):715-725
doi: https://doi.org/10.1007/s40273-018-0758-7

EQ-5D-5L Valuation for the Malaysian Population

Shafie AA, Vasan Thakumar A, Lim CJ, Luo N, Rand-Hendriksen K, Md Yusof FA.

A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms

Quality of Life Research. 2019 May;28(5):1129-1143
doi: https://doi.org/10.1007/s11136-018-2043-9

A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms

Michel YA, Augestad LA, Barra M, Rand K.

Stroke incidence in the young: evidence from a Norwegian register study

Journal of Neurology. 2019 Jan;266(1):68-84
doi: https://doi.org/10.1007/s00415-018-9102-6

Stroke incidence in the young: evidence from a Norwegian register study

Barra M, Labberton AS, Faiz KW, Lindstrøm JC, Rønning OM, Viana J, Dahl FA, Rand K.

Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

Value in Health. 2019 Jan;22(1):23-30
doi: https://doi.org/10.1016/j.jval.2018.05.010

Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol

Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goñi JM.

Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst

Substance Abuse: Research and Treatment. 2019 Aug 15;13:1178221819866181
doi: https://doi.org/10.1177/1178221819866181

Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst

Brorson HH, Arnevik EA, Rand K.

Quality-Adjusted Life-Years without Constant Proportionality

Value in Health. 2018 Sep;21(9):1124-1131
doi: https://doi.org/10.1016/j.jval.2018.02.004

Quality-Adjusted Life-Years without Constant Proportionality

Craig BM, Rand K, Bailey H, Stalmeier PFM.

Comparing 15D Valuation Studies in Norway and Finland-Challenges When Combining Information from Several Valuation Tasks

Value in Health. 2018 Apr;21(4):462-470
doi: https://doi.org/10.1016/j.jval.2017.09.018

Comparing 15D Valuation Studies in Norway and Finland-Challenges When Combining Information from Several Valuation Tasks

Michel YA, Augestad LA, Rand K.

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

Value in Health. 2017 Jul-Aug;20(7):945-952
doi: https://doi.org/10.1016/j.jval.2017.03.013

Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values

Rand-Hendriksen K, Ramos-Goñi JM, Augestad LA, Luo N.

Comparison of health state values derived from patients and individuals from the general population

Quality of Life Research. 2017 Dec;26(12):3353-3363
doi: https://doi.org/10.1007/s11136-017-1683-5

Comparison of health state values derived from patients and individuals from the general population

Gandhi M, Tan RS, Ng R, Choo SP, Chia WK, Toh CK, Lam C, Lee PT, Latt NKZ, Rand-Hendriksen K, Cheung YB, Luo N.

Estimating an EQ-5D-5L Value Set for China

Value in Health. 2017 Apr;20(4):662-669
doi: https://doi.org/10.1016/j.jval.2016.11.016

Estimating an EQ-5D-5L Value Set for China

Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K.

Influenced from the start: anchoring bias in time trade-off valuations

Quality of Life Research. 2016 Sep;25(9):2179-91
doi: https://doi.org/10.1007/s11136-016-1266-x

Influenced from the start: anchoring bias in time trade-off valuations

Augestad LA, Stavem K, Kristiansen IS, Samuelsen CH, Rand-Hendriksen K.

"When I saw walking I just kind of took it as wheeling": interpretations of mobility-related items in generic, preference-based health state instruments in the context of spinal cord injury

Health and Quality of Life Outcomes. 2016 Nov 28;14(1):164
doi: https://doi.org/10.1186/s12955-016-0565-9

"When I saw walking I just kind of took it as wheeling": interpretations of mobility-related items in generic, preference-based health state instruments in the context of spinal cord injury

Michel YA, Engel L, Rand-Hendriksen K, Augestad LA, Whitehurst DG.

Learning and satisficing: an analysis of sequence effects in health valuation

Value in Health. 2015 Mar;18(2):217-23
doi: https://doi.org/10.1016/j.jval.2014.11.005

Learning and satisficing: an analysis of sequence effects in health valuation

Craig BM, Runge SK, Rand-Hendriksen K, Ramos-Goñi JM, Oppe M.

Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation

Quality of Life Research. 2013 May;22(4):705-14
doi: https://doi.org/10.1007/s11136-012-0192-9

Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation

Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS.

Drop-out from addiction treatment: a systematic review of risk factors

Clinical Psychology Review. 2013 Dec;33(8):1010-24
doi: https://doi.org/10.1016/j.cpr.2013.07.007

Drop-out from addiction treatment: a systematic review of risk factors

Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F.

Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states

Value in Health. 2012 Jul-Aug;15(5):777-82
doi: https://doi.org/10.1016/j.jval.2012.04.002

Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states

Rand-Hendriksen K, Augestad LA.

Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions

Quality of Life Research. 2012 Aug;21(6):1005-12
doi: https://doi.org/10.1007/s11136-011-0016-3

Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions

Rand-Hendriksen K, Augestad LA, Kristiansen IS, Stavem K.

US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples

Quality of Life Research. 2020 Oct 6
doi: https://doi.org/10.1007/s11136-020-02650-y

US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples

Jiang R, Janssen MFB, Pickard AS.

Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off

Quality of Life Research. 2020 Nov 28
doi: https://doi.org/10.1007/s11136-020-02712-1

Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off

Jiang R, Shaw J, Mühlbacher A, Lee TA, Walton S, Kohlmann T, Norman R, Pickard AS.

Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings

Quality of Life Research. 2020 Oct;29(10):2651-2660
doi: https://doi.org/10.1007/s11136-020-02520-7

Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings

Joseph RW, Liu FX, Shillington AC, Macahilig CP, Diede SJ, Dave V, Harshaw Q, Saretsky TL, Pickard AS.

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Value in Health. 2019 Mar;22(3):267-275
doi: https://doi.org/10.1016/j.jval.2019.01.004

Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report

Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B. Cruz L, Karnon J, Lloyd A. Paisley S, Pickard AS.

Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy

Pediatric Pulmonology. 2019 Feb;54(2):179-185
doi: https://doi.org/10.1002/ppul.24203

Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy

Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R.

Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment

Journal of Patient-Reported Outcomes. 2017;2(1):13
doi: https://doi.org/10.1186/s41687-018-0032-y

Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment

Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS.

Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers

Journal of Comparative Effectiveness Research. 2018 Feb;7(2):177-180
doi: https://doi.org/10.2217/cer-2017-0057

Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers

Schumock GT, Pickard AS.

3L, 5L, What the L? A NICE Conundrum

PharmacoEconomics. 2018 Jun;36(6):637-640
doi: https://doi.org/10.1007/s40273-018-0622-9

3L, 5L, What the L? A NICE Conundrum

Devlin N, Brazier J, Pickard AS, Stolk E.

Patient Experience-based Value Sets: Are They Stable?

Medical Care. 2017 Nov;55(11):979-984
doi: https://doi.org/10.1097/MLR.0000000000000802

Patient Experience-based Value Sets: Are They Stable?

Pickard AS, Hung YT, Lin FJ, Lee TA.

The societal cost of heroin use disorder in the United States

PLoS One. 2017 May 30;12(5):e0177323
doi: https://doi.org/10.1371/journal.pone.0177323

The societal cost of heroin use disorder in the United States

Jiang R, Lee I, Lee TA, Pickard AS.

EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis

Journal of Medical Economics. 2017 Jan;20(1):19-27
doi: https://doi.org/10.1080/13696998.2016.1219359

EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis

Pickard AS, Gooderham M, Hartz S, Nicolay C.

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30

Quality of Life Research. 2016 Mar;25(3):625-36
doi: https://doi.org/10.1007/s11136-015-1217-y

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30

King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)

PharmacoEconomics. 2015 Aug;33(8):867-77
doi: https://doi.org/10.1007/s40273-015-0292-9

A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)

Xie F, Pickard AS, Krabbe PF, Revicki D, Viney R, Devlin N, Feeny D.

Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors

Journal of Managed Care & Specialty Pharmacy. 2015 Feb;21(2):114-22
doi: https://doi.org/10.18553/jmcp.2015.21.2.114

Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors

Ursan ID, Jiang R, Pickard EM, Lee TA, Ng D, Pickard AS.

Using linked electronic data to validate algorithms for health outcomes in administrative databases

Journal of Comparative Effectiveness Research. 2015;4(4):359-66
doi: https://doi.org/10.2217/cer.15.14

Using linked electronic data to validate algorithms for health outcomes in administrative databases

Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT.

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

Value in Health. 2012 Jul;15(5):708-15
doi: https://doi.org/10.1016/j.jval.2012.02.008

Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS.

Disease-specific patient reported outcome tools for systemic lupus erythematosus

Seminars in Arthritis and Rheumatism. 2012 Aug;42(1):56-65
doi: https://doi.org/10.1016/j.semarthrit.2011.12.005

Disease-specific patient reported outcome tools for systemic lupus erythematosus

Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ.

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial

European Journal of Cancer. 2012 Feb;48(3):311-323
doi: https://doi.org/10.1016/j.ejca.2011.05.017

Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial

Cella D, Pickard AS, Duh MS, Guerin A, Mishagina N, Antràs L, Neary MP, McCann L, Hodge R, Sternberg CN.

The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility

Health Services Research. 2011 Aug;46(4):1104-1123
doi: https://doi.org/10.1111/j.1475-6773.2011.01273.x

The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility

Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM.

Outcome, toxicity profile and cost analysis of autologous stem cell mobilization

Bone Marrow Transplantation. 2011 Aug;46(8):1084-8
doi: https://doi.org/10.1038/bmt.2010.254

Outcome, toxicity profile and cost analysis of autologous stem cell mobilization

Jagasia MH, Savani BN, Neff A, Dixon S, Chen H, Pickard AS.

Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease

Archives of Internal Medicine. 2009 Aug 10;169(15):1403-10
doi: https://doi.org/10.1001/archinternmed.2009.233

Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease

Lee TA, Wilke CT, Joo M, Stroupe KT, Krishnan J, Schumock GT, Pickard AS.

Proxy assessment of HRQL in African American and white respondents with prostate cancer:  the importance of perspective

Medical Care. 2009 Feb;47(2):176-83
doi: https://doi.org/10.1097/MLR.0b013e31818475f4

Proxy assessment of HRQL in African American and white respondents with prostate cancer: the importance of perspective

Pickard AS, Lin HW, Knight SJ, Hung S-Y, Chang C-H, Sharifi R, Bennett CL.

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

Health and Quality of Life Outcomes. 2007 Dec 21;5:70
doi: https://doi.org/10.1186/1477-7525-5-70

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

Pickard AS, Neary M, Cella D.

Evaluating Equivalency Between Response Systems: Application of the Rasch Model to a 3-Level and 5-Level EQ-5D

Medical Care. 2007 Sept;45(9):812-819
doi: https://doi.org/10.1097/MLR.0b013e31805371aa

Evaluating Equivalency Between Response Systems: Application of the Rasch Model to a 3-Level and 5-Level EQ-5D

Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D.

Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain

The European Journal of Health Economics . 2014 Dec;15(9):917-25
doi: https://doi.org/10.1007/s10198-013-0534-8

Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain

Hidalgo-Vega A, Ramos-Goñi JM, Villoro R.

Avoidable costs of physical treatments for chronic back, neck and shoulder pain within the Spanish National Health Service: a cross-sectional study

BMC Musculoskeletal Disorders . 2011 Dec 21;12:287
doi: https://doi.org/10.1186/1471-2474-12-287

Avoidable costs of physical treatments for chronic back, neck and shoulder pain within the Spanish National Health Service: a cross-sectional study

Serrano-Aguilar P, Kovacs FM, Cabrera-Hernández JM, Ramos-Goñi JM, García-Pérez L.

Cost-Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

Obesity Surgery. 2014 Dec;24(12):2061-8
doi: https://doi.org/10.1007/s11695-014-1304-0

Cost-Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

Castilla I, Mar J, Valcárcel-Nazco C, Arrospide A, Ramos-Goñi JM.

eq5dds: A command to analyze the descriptive system of EQ-5D quality-of-life instrument

The Stata Journal. 2016;16(3):691-701
doi: NA

eq5dds: A command to analyze the descriptive system of EQ-5D quality-of-life instrument

Ramos-Goñi JM, Ramallo-Fariña Y.

Choice Defines Value: A Predictive Modeling Competition in Health Preference Research

Value in Health. 2018 Feb;21(2):229-238
doi: https://doi.org/10.1016/j.jval.2017.09.016

Choice Defines Value: A Predictive Modeling Competition in Health Preference Research

Jakubczyk M, Craig BM, Barra M, Groothuis-Oudshoorn CGM, Hartman JD, Huynh E, Ramos-Goñi JM, Stolk EA, Rand K.

Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?

Health Policy. 2019; Vol 123(2): 152-158
doi: https://doi.org/10.1016/j.healthpol.2018.11.015

Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?

Lopez-Bastida J, Ramos-Goni JM, Aranda-Reneo I, Trapero-Bertran M, Kanavos P, Rodriguez Martin B.

Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models

Gaceta Sanitaria. 2020 Jan-Feb;34(1):91-95
doi: https://doi.org/10.1016/j.gaceta.2018.09.003

Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models

Arrospide A, Ramos-Goñi JM, Pechlivanoglou P, Mar J.

A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

The Patient - Patient-Centered Outcomes Research . 2020 Jun;13(3):317-325
doi: https://doi.org/10.1007/s40271-019-00407-5

A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective

Louis E, Ramos-Goni JM, Cuervo J, Kopylov U, Barreiro-de Acosta M, McCartney S, Rosenfeld G, Bettenworth D, Hart A, Novak K, Donnet X, Easton D, Saldana R, Protze K, Tzur E, Alperovich G, Casellas F.

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement

PharmacoEconomics. 2015 Oct;33(10):985-91
doi: https://doi.org/10.1007/s40273-015-0319-2

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Quality Control Process for EQ-5D-5L Valuation Studies

Value in Health. 2017 Mar;20(3):466-473
doi: https://doi.org/10.1016/j.jval.2016.10.012

Quality Control Process for EQ-5D-5L Valuation Studies

Ramos-Goñi JM, Oppe M, Slaap B, Busschbach JJ, Stolk E.

Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping

Medical Decision Making. 2006;26(1):18-29
doi: https://doi.org/10.1177/0272989X05284108

Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping

Gray AM, Rivero-Arias O, Clarke PM.

Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome

Medical Decision Making. 2010;30(3):341-54
doi: https://doi.org/10.1177/0272989X09349961

Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome

Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.

The multinational nature of cost-effectiveness analyses alongside multinational clinical trials

Value in Health. 2009;13(1):34-41
doi: https://doi.org/10.1111/j.1524-4733.2009.00582.x

The multinational nature of cost-effectiveness analyses alongside multinational clinical trials

Rivero-Arias O, Gray A.

Epidemiology of fragile X syndrome: a systematic review and meta-analysis

American Journal of Medical Genetics Part A. 2014;164(7):1648-58
doi: https://doi.org/10.1002/ajmg.a.36511

Epidemiology of fragile X syndrome: a systematic review and meta-analysis

Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J.

Mapping EQ-5D utility scores from the PedsQL generic core scales

PharmacoEconomics. 2014;32(7):693-706
doi: https://doi.org/10.1007/s40273-014-0153-y

Mapping EQ-5D utility scores from the PedsQL generic core scales

Khan KA, Petrou S, Rivero-Arias O, Walters SJ, Boyle SE.

The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration

PharmacoEconomics. 2015;33(10):993-1011
doi: https://doi.org/10.1007/s40273-015-0312-9

The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration

Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.

Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach

Medical Care. 2017;55(7):e51-e8
doi: https://doi.org/10.1097/MLR.0000000000000283

Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach

Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O.

Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

Value in Health. 2018;21(5):596-604
doi: https://doi.org/10.1016/j.jval.2017.10.023

Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach

Ramos-Goñi JM, Craig BM, Oppe M, Ramallo-Fariña Y, Pinto-Prades JL, Luo N, Rivero-Arias O.

Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong

The Patient - Patient-Centered Outcomes Research . 2018;11(2):235-47
doi: https://doi.org/10.1007/s40271-017-0278-0

Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong

Wong ELY, Ramos-Goni JM, Cheung AWL, Wong AYK, Rivero-Arias O.

Patient preferences for management of high blood pressure in the UK: a discrete choice experiment

British Journal of General Practice. 2019;69(686):e629-e37
doi: https://doi.org/10.3399/bjgp19X705101

Patient preferences for management of high blood pressure in the UK: a discrete choice experiment

Fletcher B, Hinton L, McManus R, Rivero-Arias O.

Exploring women's preferences for birth settings in England: A discrete choice experiment

PloS One. 2019;14(4):e0215098
doi: https://doi.org/10.1371/journal.pone.0215098

Exploring women's preferences for birth settings in England: A discrete choice experiment

Fletcher BR, Rowe R, Hollowell J, Scanlon M, Hinton L, Rivero-Arias O.

Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial

Health Expectations. 2020 Feb;23(1):202-11
doi: https://doi.org/10.1111/hex.12992

Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial

Campbell HE, Gray AM, Watson J, Jackson C, Moseley C, Cruickshank ME, Kitchener HC, Rivero-Arias O.

Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling

PharmacoEconomics. 2020 May;38(5):499-513
doi: https://doi.org/10.1007/s40273-020-00884-9

Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling

Dalziel K, Catchpool M, Garcia-Lorenzo B, Gorostiza I, Norman R, Rivero-Arias O.

Scoring system to facilitate diagnosis of Gaucher disease

Internal Medicine Journal. 2020 Dec;50(12):1538-46
doi: https://doi.org/10.1111/imj.14942

Scoring system to facilitate diagnosis of Gaucher disease

Mehta A, Rivero-Arias O, Abdelwahab M, Campbell S, McMillan A, Rolfe MJ, Bright JR, Kuter DJ.

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

PharmacoEconomics. 2016 Oct;34(10):993-1004
doi: https://doi.org/10.1007/s40273-016-0404-1

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes

Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N.

United States Valuation of EQ-5D-5L Health States Using an International Protocol

Value in Health. 2019 Aug;22(8):931-941
doi: https://doi.org/10.1016/j.jval.2019.02.009

United States Valuation of EQ-5D-5L Health States Using an International Protocol

Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV.

International Valuation Protocol for the EQ-5D-Y-3L

PharmacoEconomics. 2020 Jul;38(7):653-663
doi: https://doi.org/10.1007/s40273-020-00909-3

International Valuation Protocol for the EQ-5D-Y-3L

Ramos-Goñi JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N.

eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument

The Stata Journal. Volume 11 Number 1: pp. 120-125
doi: NA

eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument

Ramos-Goñi JM, Rivero-Arias O.